Oxford Financial Group LTD Corcept Therapeutics Inc Transaction History

Oxford Financial Group LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 10, 2021	SELL	$23.49 - $30.56 $4.86 Million - $6.33 Million	-206,982 Closed	0 $0
Q4 2020 Feb 10, 2021	SELL	$16.78 - $27.3 $2.19 Million - $3.56 Million	-130,454 Reduced 38.66%	206,982 $5.42 Million
Q3 2020 Nov 12, 2020	BUY	$12.46 - $19.98 $62,300 - $99,900	5,000 Added 1.5%	337,436 $5.87 Million
Q1 2020 May 12, 2020	BUY	$10.11 - $14.04 $3.36 Million - $4.67 Million	332,436 New	332,436 $3.95 Million

347

86.6M

1.12M

667K

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $5.82B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

Get notified when there are updates to the investment portfolio of Oxford Financial Group LTD, based on Form 13F filings with the SEC.

Stay updated on Oxford Financial Group LTD with notifications on news.